Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients

Baralee Punyawudho; Narukjaporn Thammajaruk; Parawee Thongpeang; Gail Matthews; Sharon R Lewin; David Burger; Kiat Ruxrungtham; Anchalee Avihingsanon

Journal article

Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients

Baralee Punyawudho, Narukjaporn Thammajaruk, Parawee Thongpeang, Gail Matthews, Sharon R Lewin, David Burger, Kiat Ruxrungtham, Anchalee Avihingsanon

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | DUSTRI-VERLAG DR KARL FEISTLE | Published : 2015

DOI: 10.5414/CP202386

University of Melbourne Researchers

Sharon Lewin Author Doherty Institute

Related Projects (1)

Hiv-Hbv Co-Infection

Morbidity and mortality secondary to liver disease is greatly increased in people co-infected with HIV and HBV compared to those infected wi..

Grants

Awarded by Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University

Awarded by National Research Council of Thailand (NRCT)

Awarded by Thailand Research Fund (TRF)

Funding Acknowledgements

This work was supported by Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University (R-004-2555); the National Research Council of Thailand (NRCT) under grant number PorKor/2554-136 and PorKor/2553-112; the Thailand Research Fund (TRF) under grant number RSA5380002 and TRG5780304; and the Aligning Care and Prevention of HIV/AIDS with Government Decentralization to Achieve Coverage and Impact: ACHIEVED Project (Global Fund Thailand).